Solara Active Pharma Sciences Ltd PE Ratio

Solara Active Pharma Sciences PE Ratio

Image

Solara Active Pharma Sciences Ltd

NSE: SOLARA

PE

-

Last updated on: Feb 20, 2026

Key Highlights

  • The P/E Ratio of Solara Active Pharma Sciences Ltd is 0 as of 20 Feb 26 The P/E Ratio of Solara Active Pharma Sciences Ltd changed from 22.6 on March 2021 to 3943 on March 2025 . This represents a CAGR of 180.78% over 5 years .

Historical P/E Ratio of Solara Active Pharma Sciences Ltd

No data available

Company Fundamentals for Solara Active Pharma Sciences Ltd

Image

Solara Active Pharma Sciences Ltd

NSE: SOLARA

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Solara Active Pharma Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Solara Active Pharma Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 2026472.1
19 Feb 2026478.15
18 Feb 2026478.2
17 Feb 2026484.7
16 Feb 2026486.35
13 Feb 2026499.6
12 Feb 2026480.1
11 Feb 2026488.1
10 Feb 2026490.45
09 Feb 2026478.4

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Solara Active Pharma Sciences Ltd

Asset Value vs Market Value of Solara Active Pharma Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Solara Active Pharma Sciences Ltd

X

Historical Market Cap of Solara Active Pharma Sciences Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Solara Active Pharma Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Solara Active Pharma Sciences Ltd

No data available

* All values are in %

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.

Solara Active Pharma Sciences Ltd News Hub

Solara Active Pharma Sciences schedules AGM

Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be

Read more

30 Aug 24

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to p

Read more

07 Feb 25

Solara Active Pharma Sciences reports consolidated net profit of Rs 8.01 crore in the September 2024 quarter

Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September

Read more

21 Oct 24

Solara Active Pharma Sciences allots 49,000 equity shares under ESOP

Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Power

Read more

21 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions